Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 813.10
-20.00 (-2.40%)
Jun 1, 2026, 3:30 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 17.16 billion as of June 1, 2026. Its market cap has decreased by -18.00% in one year.
Market Cap
17.16B
Enterprise Value
14.81B
Revenue
9.04B
Ranking
n/a
PE Ratio
26.10
Stock Price
813.10
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 17.16B, an increase of 93.40%. That is a compound annual growth rate of 14.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 17.16B | 2.99% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 57.41B |
| Innova Captab | 48.66B |
| Orchid Pharma | 40.19B |
| RPG Life Sciences | 36.79B |
| Solara Active Pharma Sciences | 25.66B |
| Indoco Remedies | 19.35B |
| Sakar Healthcare | 17.72B |
| Beta Drugs | 14.43B |